By Joseph Constance
Remote patient monitoring (RPM) and virtual, decentralized, clinical trials have gained momentum as the pharmaceutical industry harnesses these strategies to tackle COVID-19-induced clinical trial disruptions.
These strategies have been percolating in the background for some time. They would have appeared eventually, even without COVID-19. While we are part of an industry that likes to consider change pensively, the pandemic spurred their use as companies look to technology to keep the business of running clinical trials as close to schedule as possible.
And these strategies are here to stay, with the benefits and advantages they offer, playing an integral part in the move toward patient centricity. RPM is about more than technology. It’s part of a larger equation to make clinical trials more accessible to participants. RPM helps patients center around the clinical trial protocol. It provides subtle notifications and guidance along the patient journey. You might even harness RPM technologies to combine data from different sources to identify novel outcomes.
RPM utilizes digital technologies to collect medical and other heal...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).